Chinese expert consensus on standard technical specifications for a gut microecomics laboratory (Review)
- Authors:
- Zhi Guo
- Yumeng Lei
- Qiang Wang
-
Affiliations: Department of Hematology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, Guangdong 518052, P.R. China, Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, P.R. China - Published online on: August 20, 2024 https://doi.org/10.3892/etm.2024.12692
- Article Number: 403
-
Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Sommer F, Anderson JM, Bharti R, Raes J and Rosenstiel P: The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol. 15:630–638. 2017.PubMed/NCBI View Article : Google Scholar | |
Tumor and Microecology Committee of Chinese Anti-Cancer Association. Chinese expert consensus on the correlation between intestinal microecology and hematopoietic stem cell transplantation. J Inte Oncol. 48:129–135. 2021. | |
Khoruts A, Staley C and Sadowsky MJ: Faecal microbiota transplantation for Clostridioides difficile: Mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol. 18:67–80. 2021.PubMed/NCBI View Article : Google Scholar | |
Wang J, Liang J, He M, Xie Q, Wu Q, Shen G, Zhu B, Yu J, Yu L, Tan X, et al: Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022). J Cancer Res Ther. 18:1835–1844. 2022.PubMed/NCBI View Article : Google Scholar | |
Chahwan B, Kwan S, Isik A, van Hemert S, Burke C and Roberts L: Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms. J Affect Disord. 253:317–326. 2019.PubMed/NCBI View Article : Google Scholar | |
Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, et al: Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 342:967–970. 2013.PubMed/NCBI View Article : Google Scholar | |
Microecology Branch of Chinese Preventive Medicine Association. Expert consensus on clinical application of microecological regulators in China (2020 edition). Chin J Microecol. 32:953–965. 2020. | |
Johnson JS, Spakowicz DJ, Hong BY, Petersen LM, Demkowicz P, Chen L, Leopold SR, Hanson BM, Agresta HO, Gerstein M, et al: Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 10(5029)2019.PubMed/NCBI View Article : Google Scholar | |
Zhang W, Fan X, Shi H, Li J, Zhang M, Zhao J and Su X: Comprehensive Assessment of 16S rRNA gene amplicon sequencing for microbiome profiling across multiple habitats. Microbiol Spectr. 11(e0056323)2023.PubMed/NCBI View Article : Google Scholar | |
Rutsch A, Kantsjö JB and Ronchi F: The Gut-Brain axis: How microbiota and host inflammasome influence brain physiology and pathology. Front Immunol. 11(604179)2020.PubMed/NCBI View Article : Google Scholar | |
Ansaldo E, Farley TK and Belkaid Y: Control of immunity by the microbiota. Annu Rev Immunol. 39:449–479. 2021.PubMed/NCBI View Article : Google Scholar | |
Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, et al: The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 342:971–976. 2013.PubMed/NCBI View Article : Google Scholar | |
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al: Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 359:91–97. 2028.PubMed/NCBI View Article : Google Scholar | |
Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al: Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 359:97–103. 2018.PubMed/NCBI View Article : Google Scholar | |
Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, Narushima S, Vlamakis H, Motoo I, Sugita K, et al: A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 565:600–605. 2019.PubMed/NCBI View Article : Google Scholar | |
Fluckiger A, Daillère R, Sassi M, Sixt BS, Liu P, Loos F, Richard C, Rabu C, Alou MT, Goubet AG, et al: Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Science. 369:936–942. 2020.PubMed/NCBI View Article : Google Scholar | |
Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, et al: Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 350:1084–1089. 2015.PubMed/NCBI View Article : Google Scholar | |
Zhang T, Li Q, Cheng L, Buch H and Zhang F: Akkermansia muciniphila is a promising probiotic. Microb Biotechnol. 12:1109–1125. 2019.PubMed/NCBI View Article : Google Scholar | |
Donald K and Finlay BB: Early-life interactions between the microbiota and immune system: Impact on immune system development and atopic disease. Nat Rev Immunol. 23:735–748. 2023.PubMed/NCBI View Article : Google Scholar | |
Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A and Mele MC: What is the Healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 7(14)2019.PubMed/NCBI View Article : Google Scholar | |
Parikh K, Antanaviciute A, Fawkner-Corbett D, Jagielowicz M, Aulicino A, Lagerholm C, Davis S, Kinchen J, Chen HH, Alham NK, et al: Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature. 567:49–55. 2019.PubMed/NCBI View Article : Google Scholar | |
Yu J, Yin Y, Yu Y, Cheng M, Zhang S, Jiang S and Dong M: Effect of concomitant antibiotics use on patient outcomes and adverse effects in patients treated with ICIs. Immunopharmacol Immunotoxicol. 45:386–394. 2023.PubMed/NCBI View Article : Google Scholar | |
Liu X, Tong X, Zou Y, Lin X, Zhao H, Tian L, Jie Z, Wang Q, Zhang Z, Lu H, et al: Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat Genet. 54:52–61. 2022.PubMed/NCBI View Article : Google Scholar | |
Zitvogel L, Ma Y, Raoult D, Kroemer G and Gajewski TF: The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science. 359:1366–1370. 2018.PubMed/NCBI View Article : Google Scholar | |
Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, Luke JJ and Gajewski TF: The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 359:104–108. 2018.PubMed/NCBI View Article : Google Scholar | |
Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, Paik S, Stagg J, Groves RA, Gallo M, et al: Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 369:1481–1489. 2020.PubMed/NCBI View Article : Google Scholar | |
Kim J and Lee HK: Potential Role of the gut microbiome in colorectal cancer progression. Front Immunol. 12(807648)2022.PubMed/NCBI View Article : Google Scholar | |
Wang N and Fang JY: Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Trends Microbiol. 31:159–172. 2023.PubMed/NCBI View Article : Google Scholar | |
Yang Y, Du L, Shi D, Kong C, Liu J, Liu G, Li X and Ma Y: Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nat Commun. 12(6757)2021.PubMed/NCBI View Article : Google Scholar | |
Kartal E, Schmidt TSB, Molina-Montes E, Rodríguez-Perales S, Wirbel J, Maistrenko OM, Akanni WA, Alashkar Alhamwe B, Alves RJ, Carrato A, et al: A faecal microbiota signature with high specificity for pancreatic cancer. Gut. 71:1359–1372. 2022.PubMed/NCBI View Article : Google Scholar | |
Lee JWJ, Plichta D, Hogstrom L, Borren NZ, Lau H, Gregory SM, Tan W, Khalili H, Clish C, Vlamakis H, et al: Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. Cell Host Microbe. 29:1294–1304. 2021.PubMed/NCBI View Article : Google Scholar | |
Young VB: The role of the microbiome in human health and disease: An introduction for clinicians. BMJ. 356(j831)2017.PubMed/NCBI View Article : Google Scholar | |
Jian Y, Zhang D, Liu M, Wang Y and Xu ZX: The impact of gut microbiota on radiation-induced enteritis. Front Cell Infect Microbiol. 11(586392)2021.PubMed/NCBI View Article : Google Scholar | |
Wang L, Wang X, Zhang G, Ma Y, Zhang Q, Li Z, Ran J, Hou X, Geng Y, Yang Z, et al: The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: A systematic review. Radiat Oncol. 16(187)2021.PubMed/NCBI View Article : Google Scholar | |
Samarkos M, Mastrogianni E and Kampouropoulou O: The role of gut microbiota in Clostridium difficile infection. Eur J Intern Med. 50:28–32. 2018.PubMed/NCBI View Article : Google Scholar | |
Shogbesan O, Poudel DR, Victor S, Jehangir A, Fadahunsi O, Shogbesan G and Donato A: A systematic review of the efficacy and safety of fecal microbiota transplant for clostridium difficile infection in immunocompromised patients. Can J Gastroenterol Hepatol. 2018(1394379)2018.PubMed/NCBI View Article : Google Scholar | |
Boulangé CL, Neves AL, Chilloux J, Nicholson JK and Dumas ME: Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 8(42)2016.PubMed/NCBI View Article : Google Scholar | |
Li S, He M, Lei Y, Liu Y, Li X, Xiang X, Wu Q and Wang Q: Oral microbiota and Tumor-A new perspective of tumor pathogenesis. Microorganisms. 10(2206)2022.PubMed/NCBI View Article : Google Scholar | |
Diakite A, Dubourg G, Dione N, Afouda P, Bellali S, Ngom II, Valles C, Tall ML, Lagier JC and Raoult D: Optimization and standardization of the culturomics technique for human microbiome exploration. Sci Rep. 10(9674)2020.PubMed/NCBI View Article : Google Scholar | |
Goren E, Wang C, He Z, Sheflin AM, Chiniquy D, Prenni JE, Tringe S, Schachtman DP and Liu P: Feature selection and causal analysis for microbiome studies in the presence of confounding using standardization. BMC Bioinformatics. 22(362)2021.PubMed/NCBI View Article : Google Scholar | |
Laudadio I, Fulci V, Palone F, Stronati L, Cucchiara S and Carissimi C: Quantitative assessment of shotgun metagenomics and 16S rRNA amplicon sequencing in the study of human gut microbiome. OMICS. 22:248–254. 2018.PubMed/NCBI View Article : Google Scholar | |
Kryukov K, Imanishi T and Nakagawa S: Nanopore sequencing data analysis of 16S rRNA genes using the GenomeSync-GSTK system. Methods Mol Biol. 2632:215–226. 2023.PubMed/NCBI View Article : Google Scholar | |
Zhang T, Li H, Ma S, Cao J, Liao H, Huang Q and Chen W: The newest oxford Nanopore R10.4.1 full-length 16S rRNA sequencing enables the accurate resolution of species-level microbial community profiling. Appl Environ Microbiol. 89(e0060523)2023.PubMed/NCBI View Article : Google Scholar | |
Deng X, Achari A, Federman S, Yu G, Somasekar S, Bártolo I, Yagi S, Mbala-Kingebeni P, Kapetshi J, Ahuka-Mundeke S, et al: Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance. Nat Microbiol. 5:443–454. 2020.PubMed/NCBI View Article : Google Scholar | |
Shi Y, Wang G, Lau HC and Yu J: Metagenomic sequencing for Microbial DNA in human samples: Emerging technological advances. Int J Mol Sci. 23(2181)2022.PubMed/NCBI View Article : Google Scholar | |
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464:59–65. 2010.PubMed/NCBI View Article : Google Scholar | |
Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP and Wilcox MH: Clinical practice guideline by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA): 2021 Focused update guidelines on management of clostridioides difficile infection in adults. Clin Infect Dis. 73:e1029–e1044. 2021.PubMed/NCBI View Article : Google Scholar | |
Eltokhy MA, Saad BT, Eltayeb WN, El-Ansary MR, Aboshanab KM and Ashour MSE: A metagenomic nanopore sequence analysis combined with conventional screening and spectroscopic methods for deciphering the antimicrobial metabolites produced by alcaligenes faecalis soil isolate MZ921504. Antibiotics (Basel). 10(1382)2021.PubMed/NCBI View Article : Google Scholar | |
Guan H, Pu Y, Liu C, Lou T, Tan S, Kong M, Sun Z, Mei Z, Qi Q, Quan Z, et al: Comparison of fecal collection methods on variation in gut metagenomics and untargeted metabolomics. mSphere. 6(e0063621)2021.PubMed/NCBI View Article : Google Scholar | |
Mordant A and Kleiner M: Evaluation of sample preservation and storage methods for metaproteomics analysis of intestinal microbiomes. Microbiol Spectr. 9(e0187721)2021.PubMed/NCBI View Article : Google Scholar | |
Haindl R, Totzauer L and Kulozik U: Preservation by lyophilization of a human intestinal microbiota: Influence of the cultivation pH on the drying outcome and re-establishment ability. Microb Biotechnol. 15:886–900. 2022.PubMed/NCBI View Article : Google Scholar | |
China Preventive Medicine Association. General Guidelines for Pathogen Screening based on High-throughput Sequencing (T/CMPA 010-2020). J Pathogen Biology. 16:738–740. 2021. | |
Xiao W, Ren L, Chen Z, Fang LT, Zhao Y, Lack J, Guan M, Zhu B, Jaeger E, Kerrigan L, et al: Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nat Biotechnol. 39:1141–1150. 2021.PubMed/NCBI View Article : Google Scholar | |
Poulsen CS, Ekstrøm CT, Aarestrup FM and Pamp SJ: Library preparation and sequencing platform introduce bias in metagenomic-based characterizations of microbiomes. Microbiol Spectr. 10(e0009022)2022.PubMed/NCBI View Article : Google Scholar | |
Kong N, Ng W, Thao K, Agulto R, Weis A, Kim KS, Korlach J, Hickey L, Kelly L, Lappin S and Weimer BC: Automation of PacBio SMRTbell NGS library preparation for bacterial genome sequencing. Stand Genomic Sci. 12(27)2017.PubMed/NCBI View Article : Google Scholar | |
Sanschagrin S and Yergeau E: Next-generation sequencing of 16S ribosomal RNA gene amplicons. J Vis Exp. 29(51709)2014.PubMed/NCBI View Article : Google Scholar | |
Matsuo Y: Full-Length 16S rRNA gene analysis using Long-Read nanopore sequencing for rapid identification of bacteria from clinical specimens. Methods Mol Biol. 2632:193–213. 2023.PubMed/NCBI View Article : Google Scholar | |
Jin J, Yamamoto R and Shiroguchi K: High-throughput identification and quantification of bacterial cells in the microbiota based on 16S rRNA sequencing with single-base accuracy using BarBIQ. Nat Protoc. 9:207–239. 2024.PubMed/NCBI View Article : Google Scholar | |
Ranjan R, Rani A, Metwally A, McGee HS and Perkins DL: Analysis of the microbiome: Advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun. 469:967–977. 2016.PubMed/NCBI View Article : Google Scholar | |
Laboratory Medicine Branch of Chinese Medical Association. Expert Consensus on the standardization of clinical application of high-throughput metagenomic sequencing technology to detect pathogenic microorganisms. Chin J Laboratory Med. 43:1181–1195. 2020. | |
Nash AK, Auchtung TA, Wong MC, Smith DP, Gesell JR, Ross MC, Stewart CJ, Metcalf GA, Muzny DM, Gibbs RA, et al: The gut mycobiome of the human microbiome project healthy cohort. Microbiome. 5(153)2017.PubMed/NCBI View Article : Google Scholar | |
Huang C, Callahan BJ, Wu MC, Holloway ST, Brochu H, Lu W, Peng X and Tzeng JY: Phylogeny-guided microbiome OTU-specific association test (POST). Microbiome. 10(86)2022.PubMed/NCBI View Article : Google Scholar | |
Mokhtari EB and Ridenhour BJ: Filtering ASVs/OTUs via mutual information-based microbiome network analysis. BMC Bioinformatics. 23(380)2022.PubMed/NCBI View Article : Google Scholar | |
Mao CX and Li J: Comparing species assemblages via species accumulation curves. Biometrics. 65:1063–1067. 2009.PubMed/NCBI View Article : Google Scholar | |
Sæther BE, Engen S and Grøtan V: Species diversity and community similarity in fluctuating environments: Parametric approaches using species abundance distributions. J Anim Ecol. 82:721–738. 2013.PubMed/NCBI View Article : Google Scholar | |
Shahi SK, Zarei K, Guseva NV and Mangalam AK: Microbiota analysis using Two-step PCR and Next-generation 16S rRNA gene sequencing. J Vis Exp: Oct 15, 2019 doi: 10.3791/59980. | |
Xun W, Li W, Xiong W, Ren Y, Liu Y, Miao Y, Xu Z, Zhang N, Shen Q and Zhang R: Diversity-triggered deterministic bacterial assembly constrains community functions. Nat Commun. 10(3833)2019.PubMed/NCBI View Article : Google Scholar | |
Wilmanski T, Rappaport N, Earls JC, Magis AT, Manor O, Lovejoy J, Omenn GS, Hood L, Gibbons SM and Price ND: Blood metabolome predicts gut microbiome α-diversity in humans. Nat Biotechnol. 37:1217–1228. 2019.PubMed/NCBI View Article : Google Scholar | |
R Core Team (RELEASE YEAR-year version of R used was released). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. | |
Yu X, Jiang W, Kosik RO, Song Y, Luo Q, Qiao T, Tong J, Liu S, Deng C, Qin S, et al: Gut microbiota changes and its potential relations with thyroid carcinoma. J Adv Res. 35:61–70. 2021.PubMed/NCBI View Article : Google Scholar | |
Yu X, Jiang W, Kosik RO, Song Y, Luo Q, Qiao T, Tong J, Liu S, Deng C, Qin S, et al: Gut microbiota changes and its potential relations with thyroid carcinoma. J Adv Res. 35:61–70. 2021.PubMed/NCBI View Article : Google Scholar | |
Schlaberg R: Microbiome Diagnostics. Clin Chem. 66:68–76. 2020.PubMed/NCBI View Article : Google Scholar | |
Bharti R and Grimm DG: Current challenges and best-practice protocols for microbiome analysis. Brief Bioinform. 22:178–193. 2021.PubMed/NCBI View Article : Google Scholar | |
Aly AM, Adel A, El-Gendy AO, Essam TM and Aziz RK: Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog. 8(42)2016.PubMed/NCBI View Article : Google Scholar | |
Gao Y and Wu M: Accounting for 16S rRNA copy number prediction uncertainty and its implications in bacterial diversity analyses. ISME Commun. 3(59)2023.PubMed/NCBI View Article : Google Scholar | |
Karpiński TM, Ożarowski M and Stasiewicz M: Carcinogenic microbiota and its role in colorectal cancer development. Semin Cancer Biol. 86:420–430. 2022.PubMed/NCBI View Article : Google Scholar | |
Lee M and Chang EB: Inflammatory bowel diseases (IBD) and the Microbiome-Searching the crime scene for clues. Gastroenterology. 160:524–537. 2021.PubMed/NCBI View Article : Google Scholar | |
Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M and Clément K: Metabolism and metabolic disorders and the microbiome: The intestinal microbiota associated with obesity, lipid metabolism, and metabolic Health-Pathophysiology and therapeutic strategies. Gastroenterology. 160:573–599. 2021.PubMed/NCBI View Article : Google Scholar | |
Youssef NH, Couger MB, McCully AL, Criado AE and Elshahed MS: Assessing the global phylum level diversity within the bacterial domain: A review. J Adv Res. 6:269–282. 2015.PubMed/NCBI View Article : Google Scholar | |
Zou X, Wang L, Xiao L, Wang S and Zhang L: Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies. Front Immunol. 13(975921)2022.PubMed/NCBI View Article : Google Scholar | |
Adak A and Khan MR: An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 76:473–493. 2019.PubMed/NCBI View Article : Google Scholar | |
Dash NR, Khoder G, Nada AM and Al Bataineh MT: Exploring the impact of Helicobacter pylori on gut microbiome composition. PLoS One. 14(e0218274)2019.PubMed/NCBI View Article : Google Scholar | |
Lun H, Yang W, Zhao S, Jiang M, Xu M, Liu F and Wang Y: Altered gut microbiota and microbial biomarkers associated with chronic kidney disease. Microbiologyopen. 8(e00678)2019.PubMed/NCBI View Article : Google Scholar | |
Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, et al: Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 68:1014–1023. 2019.PubMed/NCBI View Article : Google Scholar | |
Wang Q, Lei Y, Wang J, Xu X, Wang L, Zhou H and Guo Z: Tumor and Microecology Committee of China Anti-Cancer Association. Expert consensus on the relevance of intestinal microecology and hematopoietic stem cell transplantation. Clin Transplant. 38(e15186)2023.PubMed/NCBI View Article : Google Scholar | |
Li S, Wang T, Ren Y, Liu Z, Gao J and Guo Z: Prognostic impact of oral microbiome on survival of malignancies: A systematic review and meta-analysis. Syst Rev. 13(41)2024.PubMed/NCBI View Article : Google Scholar | |
Lu J, Zhang L, Zhai Q, Zhao J, Zhang H, Lee YK, Lu W, Li M and Chen W: Chinese gut microbiota and its associations with staple food type, ethnicity, and urbanization. NPJ Biofilms Microbiomes. 7(71)2021.PubMed/NCBI View Article : Google Scholar | |
Yang Q, Liang Q, Balakrishnan B, Belobrajdic DP, Feng QJ and Zhang W: Role of dietary nutrients in the modulation of gut microbiota: A narrative review. Nutrients. 12(381)2020.PubMed/NCBI View Article : Google Scholar | |
Corbin KD, Carnero EA, Dirks B, Igudesman D, Yi F, Marcus A, Davis TL, Pratley RE, Rittmann BE, Krajmalnik-Brown R and Smith SR: Host-diet-gut microbiome interactions influence human energy balance: A randomized clinical trial. Nat Commun. 14(3161)2023.PubMed/NCBI View Article : Google Scholar | |
Jacobs JP, Lagishetty V, Hauer MC, Labus JS, Dong TS, Toma R, Vuyisich M, Naliboff BD, Lackner JM, Gupta A, et al: Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. Microbiome. 11(5)2023.PubMed/NCBI View Article : Google Scholar | |
He J, Chu Y, Li J, Meng Q, Liu Y, Jin J, Wang Y, Wang J, Huang B, Shi L, et al: Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis. Sci Adv. 8(eabm1511)2022.PubMed/NCBI View Article : Google Scholar | |
Rhoads DD, Sintchenko V, Rauch CA and Pantanowitz L: Clinical microbiology informatics. Clin Microbiol Rev. 27:1025–1047. 2014.PubMed/NCBI View Article : Google Scholar | |
Patel R: New developments in clinical bacteriology laboratories. Mayo Clin Proc. 91:1448–1459. 2016.PubMed/NCBI View Article : Google Scholar | |
Rozas M, Brillet F, Callewaert C and Paetzold B: MinION™ nanopore sequencing of skin microbiome 16S and 16S-23S rRNA gene amplicons. Front Cell Infect Microbiol. 11(806476)2022.PubMed/NCBI View Article : Google Scholar | |
Hoffmann DE, von Rosenvinge EC, Roghmann MC, Palumbo FB, McDonald D and Ravel J: The DTC microbiome testing industry needs more regulation. Science. 383:1176–1179. 2024.PubMed/NCBI View Article : Google Scholar | |
Kalokairinou L, Borry P and Howard HC: ‘It's much more grey than black and white’: Clinical geneticists’ views on the oversight of consumer genomics in Europe. Per Med. 17:129–140. 2020.PubMed/NCBI View Article : Google Scholar |